LAPTM5 and lung carcinoma: Additionally, we also showed that low expression of LAPTM5 was significantly correlated with poor prognosis in NSCLC patients by analysis of lung cancer gene expression datasets that included survival information (P = 0.043) (Figure 1E) [16].